Synapse

← Molecular Biomedicine

Papers in Molecular Biomedicine

Page 6 · newest first

  1. Pharmacological inhibition of Ubiquitin-Specific Peptidase 10 (USP10) with spautin-1 attenuates adipogenesis through CCAAT/Enhancer-Binding Protein Beta (C/EBPβ) destabilizationMolecular Biomedicine · 2025
  2. Targeting tumor-infiltrating regulatory T cells: combining CD47 and PD-L1 inhibition via a novel aptamer-siRNA chimeraMolecular Biomedicine · 2025
  3. Multi-omics factor analysis identifies the Tensin 1-Fermitin family homologue 2–Fibronectin 1–Integrin signaling axis as a prognostic determinant in colorectal cancerMolecular Biomedicine · 2025
  4. Intratumoral microbiome: a crucial regulating factor in development and progression of colorectal cancerMolecular Biomedicine · 2025
  5. Th-1 cytokine-primed small extracellular vesicles from limbal mesenchymal stem cells modulate immune and inflammatory responses in Hashimoto's Thyroiditis: an ex vivo proof-of-concept studyMolecular Biomedicine · 2025
  6. Gastrointestinal cancer: molecular pathogenesis and targeted therapyMolecular Biomedicine · 2025
  7. Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort studyMolecular Biomedicine · 2025
  8. Single-cell sequencing and organoids: applications in organ development and diseaseMolecular Biomedicine · 2025
  9. Interferon signaling pathways in health and diseaseMolecular Biomedicine · 2025
  10. Neutrophil Extracellular Traps (NETs) in health and diseaseMolecular Biomedicine · 2025
  11. Decoding the role of mesothelin in tumor dynamics and targeted treatment innovationsMolecular Biomedicine · 2025
  12. Down-regulation of RBM47 due to diminished activation by forkhead box A1 (FOXA1) and silencing by CpG methylation is associated with epithelial-mesenchymal transition and metastasis of colorectal cancerMolecular Biomedicine · 2025
  13. Epigenetic drugs in cancer therapy: mechanisms, immune modulation, and therapeutic applicationsMolecular Biomedicine · 2025
  14. Cholesterol induced-mitochondrial calcium dysregulation facilitates atherosclerosis by promoting lipid accumulation in vascular smooth muscle cellsMolecular Biomedicine · 2025
  15. Identification of PIWI-interacting RNAs based models for lung adenocarcinoma early detection: a multicenter cohort studyMolecular Biomedicine · 2025
  16. Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancerMolecular Biomedicine · 2025
  17. Cholesterol induced-mitochondrial calcium dysregulation facilitates atherosclerosis by promoting lipid accumulation in vascular smooth muscle cellsMolecular Biomedicine · 2025
  18. T-cell immunoglobulin and mucin domain-containing protein 3–mediated immunomodulation in myeloid cells and keratinocytes in the development of severe acneMolecular Biomedicine · 2025
  19. Sentrin‐specific protease 3 (SENP3)-mediated Krüppel-like factor 4 (KLF4) deSUMOylation regulates vascular smooth muscle cell phenotypic switching in atherosclerosisMolecular Biomedicine · 2025
  20. Fibroblasts promote the progression of benign prostatic hyperplasia through colony-stimulating factor 1 receptor-mediated RTK signaling in prostatic epithelial cellsMolecular Biomedicine · 2025
  21. Long-chain acyl-CoA synthetases: biological functions, diseases and therapeutic targetsMolecular Biomedicine · 2025
  22. Epithelial membrane protein 1 drives hepatic stellate cell activation via the TLN1/FAK cascade in MASLD donor liver transplantationMolecular Biomedicine · 2025
  23. Ubiquitin-specific protease 13 promotes colorectal cancer progression by stabilizing mitogen-activated protein kinase kinase 3Molecular Biomedicine · 2025
  24. T-cell immunoglobulin and mucin domain-containing protein 3–mediated immunomodulation in myeloid cells and keratinocytes in the development of severe acneMolecular Biomedicine · 2025
  25. Sentrin‐specific protease 3 (SENP3)-mediated Krüppel-like factor 4 (KLF4) deSUMOylation regulates vascular smooth muscle cell phenotypic switching in atherosclerosisMolecular Biomedicine · 2025
  26. MIRA-1, a p53mut reactivator, is active on Temozolomide-resistant glioblastoma in vitroMolecular Biomedicine · 2025
  27. Obestatin treatment links mitochondrial homeostasis and skeletal muscle repair in Duchenne muscle dystrophyMolecular Biomedicine · 2025
  28. Long-chain acyl-CoA synthetases: biological functions, diseases and therapeutic targetsMolecular Biomedicine · 2025
  29. Epithelial membrane protein 1 drives hepatic stellate cell activation via the TLN1/FAK cascade in MASLD donor liver transplantationMolecular Biomedicine · 2025
  30. A single non-coding SNP in FPGS modulates folate drug efficacy in acute lymphoblastic leukemia: data-driven exploration and experimental validationMolecular Biomedicine · 2025
  31. PARP inhibitor BMN673 triggers PARylation-mediated ATF4-GDF15 pathway to drive autophagy and ferroptosis in ataxia telangiectasia mutated gene-deficient colorectal cancer cellsMolecular Biomedicine · 2025
  32. Multi-omics strategies for biomarker discovery and application in personalized oncologyMolecular Biomedicine · 2025
  33. PARP inhibitor BMN673 triggers PARylation-mediated ATF4-GDF15 pathway to drive autophagy and ferroptosis in ataxia telangiectasia mutated gene-deficient colorectal cancer cellsMolecular Biomedicine · 2025
  34. Multi-omics strategies for biomarker discovery and application in personalized oncologyMolecular Biomedicine · 2025
  35. A single non-coding SNP in FPGS modulates folate drug efficacy in acute lymphoblastic leukemia: data-driven exploration and experimental validationMolecular Biomedicine · 2025
  36. ER stress induced extracellular vesicles secretion from macrophages promotes calcium oxalate crystals formation in kidneyMolecular Biomedicine · 2025
  37. Drug resistance in cancer: molecular mechanisms and emerging treatment strategiesMolecular Biomedicine · 2025
  38. ER stress induced extracellular vesicles secretion from macrophages promotes calcium oxalate crystals formation in kidneyMolecular Biomedicine · 2025
  39. Drug resistance in cancer: molecular mechanisms and emerging treatment strategiesMolecular Biomedicine · 2025
  40. Histone methyltransferase KMT2D targets the SPOP-G3BP1 axis to enhance AR stability and drive castration-resistant prostate cancer progressionMolecular Biomedicine · 2025
  41. Metabolomics and metabolites in cancer diagnosis and treatmentMolecular Biomedicine · 2025
  42. ML345 is a potent and selective NLRP3 inflammasome inhibitor with anti-inflammatory activityMolecular Biomedicine · 2025
  43. Clinical-grade AI model for molecular subtyping of endometrial cancer: a multi-center cohort study in ChinaMolecular Biomedicine · 2025
  44. STAT3 regulates NK and NKT cell differentiation through C-X3-C motif chemokine receptor 1  (CX3CR1) in hyper-IgE syndromeMolecular Biomedicine · 2025
  45. The role of Nrf2 in anoikis resistance and metastasis in anaplastic thyroid carcinomaMolecular Biomedicine · 2025
  46. Clinical-grade AI model for molecular subtyping of endometrial cancer: a multi-center cohort study in ChinaMolecular Biomedicine · 2025
  47. STAT3 regulates NK and NKT cell differentiation through C-X3-C motif chemokine receptor 1 (CX3CR1) in hyper-IgE syndromeMolecular Biomedicine · 2025
  48. Itaconate reduces viral endocytosis by targeting Cys128 of the adaptor-related protein complex 1 gamma 1 subunit in the host, providing a novel target for antiviral drug developmentMolecular Biomedicine · 2025
  49. E3 ligase CHIP restoration facilitates the effect of α1-adrenoceptor blockage on alleviating lipopolysaccharide-caused cardiac fibrosis via downregulating TGF-BR1 expression and Smad2/3 activationMolecular Biomedicine · 2025
  50. Targeting ferroptosis and cuproptosis in gastrointestinal cancers: molecular mechanisms, metabolic vulnerabilities, and therapeutic interventionsMolecular Biomedicine · 2025